Table 1. Correlation of CCL18+ TAM counts with MVD and clinicopathological status in samples from 80 patients with breast invasive ductal carcinoma.
| CCL18+ TAM counts | ≤ 5 (n = 33) |
6–20 (n = 25) |
> 20 (n = 22) |
p value |
|---|---|---|---|---|
| MVD | ||||
| CD34 | 7.0 | 14.8 | 20.1 | 0.006 |
| CD31 | 6.1 | 12.9 | 18.5 | 0.008 |
| FVIII-ra | 6.3 | 12.6 | 17.7 | 0.023 |
| Age (years) | ||||
| ≤ 45 | 16 | 9 | 8 | 0.545 |
| > 45 | 17 | 16 | 14 | |
| Tumor Size (cm) | ||||
| ≤ 2 | 21 | 5 | 2 | < 0.001 |
| > 2 | 12 | 20 | 20 | |
| Stage | ||||
| I | 9 | 2 | 0 | 0.014 |
| II | 16 | 11 | 9 | |
| III | 8 | 12 | 13 | |
| Histological Grade | ||||
| I | 11 | 2 | 2 | 0.035 |
| II | 14 | 13 | 8 | |
| III | 8 | 10 | 12 | |
| Distant metastasis* | ||||
| Positive | 2 | 5 | 8 | 0.018 |
| Negative | 31 | 20 | 14 | |
| Lymph Node Metastasis | ||||
| 0 | 23 | 5 | 2 | < 0.001 |
| 1–3 | 8 | 12 | 10 | |
| ≥ 4 | 2 | 8 | 10 | |
| ER status | ||||
| Positive | 23 | 19 | 17 | 0.784 |
| Negative | 10 | 6 | 5 | |
| Her2 status | ||||
| Positive | 3 | 5 | 8 | 0.047 |
| Negative | 30 | 20 | 14 | |
*
Distant metastasis identified during postoperative follow-up consultation